Posted On: 12/19/2014 9:00:50 PM
Post# of 30015
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
so, did Gerald just pick up a $17,718.75 check today on Bonus Milestone #4?
***** 4 Bonus Milestones *****
1.) Nasdaq Uplist
30% Bonus = $35,437.50
2.) Eltoprazine US IND filed & Approved for LID
30% Bonus = $35,437.50
3.) LymPro Partner Validation of APP & CLIA Certification
25% Bonus = $29,531.24
4.) MANF ODD Apps Filed & Approved for OIA & RP
15% Bonus = $17,718.75
Quote:
"Filing our second Orphan Drug Designation for MANF is an important component of our regulatory strategy for the program," said Gerald E. Commissiong, President & CEO of Amarantus.
***** 4 Bonus Milestones *****
1.) Nasdaq Uplist
30% Bonus = $35,437.50
2.) Eltoprazine US IND filed & Approved for LID
30% Bonus = $35,437.50
3.) LymPro Partner Validation of APP & CLIA Certification
25% Bonus = $29,531.24
4.) MANF ODD Apps Filed & Approved for OIA & RP
15% Bonus = $17,718.75
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)